Healthy Clinical Trial
Official title:
Measurement of Maximal Oxygen Uptake (VO2max) Using Mankato Submaximal Exercise Test in Young Adults
Verified date | January 2023 |
Source | Riphah International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
- To measure the maximal oxygen uptake (VO2max) using Mankato Submaximal Exercise test. - To correlate 'true' VO2max with Modified Bruce protocol and Mankato Submaximal Exercise Test.
Status | Completed |
Enrollment | 50 |
Est. completion date | October 31, 2020 |
Est. primary completion date | October 31, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Male and female aged between 18-35 years - Individuals with normal BMI i.e. 18.5-24.9 - Individuals with positive cardiovascular family history Exclusion Criteria: - Subjects with any known cardiovascular & pulmonary disease - Subjects addicted to caffeine/ smoking - Subjects with any neuromuscular disability/deformity |
Country | Name | City | State |
---|---|---|---|
Pakistan | Railway General Hospital, Pakistan | Rawalpindi | Punjab |
Lead Sponsor | Collaborator |
---|---|
Riphah International University |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | PAR Scale | PAR scale is a self reported physical activity rating scale used for a healthy population. It describes the physical activity level of an individual from the last 6 months. It consists of scale from 0-15. | 1 Day | |
Primary | Pulse Rate | Beat per minute it is measured through Pulse Oximeter | 1 Day | |
Primary | Oxygen Saturation | It is measured in percentage of Oxygen in tissue, measured through Pulse oximeter | 1 Day | |
Primary | One Mile Walk Test | One mile walk test is also termed as Rockport Fitness Walking Test. The subject walk distance of 1 mile and take record of the time took to cover that distance. The subject's pulse rate is taken after the completion of test by pulse oximeter | 1 Day | |
Primary | VO2max Aerobic Capacity Calculator | VO2max aerobic capacity calculator is an online calculator used to measure VO2max. It calculates VO2max using the four most common methods which include, VO2max based on resting heart rate, VO2max based on one mile walk test, VO2max based on three minute step test and VO2max based on 1.5 mile walk or run test | 1 Day | |
Primary | Non-Exercise Regression Equation | Non-exercise regression equation is used for measuring VO2max based on non-exercise data. The variables required for the following equation are PAR scale, age, BMI and gender.
VO2max (ml/kg/min) = 56.363 + 1.921 × PAR - 0.381 × Age - 0.754 × BMI + 10.987 × Gender |
1 Day | |
Primary | Metabolic Equations | ACSM metabolic equations are used for measuring VO2max. These metabolic equations are mentioned in ACSM's Guidelines for Exercise Testing and Prescription 2018. Following metabolic equations are used:
Speak (m.min-1) = (VO2max - 3.5) /0.2 Running VO2max (ml/kg/min) = (0.1 × speed) + (1.8 × speed × grade) + 3.5 Walking VO2max (ml/kg/min) = (0.2 × speed) + (0.9 × speed × grade) + 3.5 |
1 Day | |
Primary | Modified Bruce protocol | Modified Bruce protocol is a treadmill protocol and modified form of Bruce protocol with decreased increment in initial stages and then increasing the slope progressively. Following are the Modified Bruce protocol stages:
Stage 0 = 1.7 mph at 0% Grade Stage 0.5 = 1.7 mph at 5% Grade Stage 1 = 1.7 mph at 10% Grade Stage 2 = 2.5 mph at 12% Grade Stage 3 = 3.4 mph at 14% Grade Stage 4 = 4.2 mph at 16% Grade Stage 5 = 5.0 mph at 18% Grade Stage 6 = 5.5 mph at 20% Grade Stage 7 = 6.0 mph at 22% Grade Stage 8 = 6.5 mph at 24% Grade |
1 Day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |